TIGIT and neoplasm: In both subcutaneous and ascites tumor models, the CD8+ T cell infiltration of mice treated with VV-α-TIGIT was much higher than that of mice treated with PBS, indicating that VV-α-TIGIT has a strong function of recruiting T cells, making the “cold” tumors “hot”.